Revolve Group Inc <RVLV.N>: Morgan Stanley raises target price to $29.00 from $27.00
RVLV•Related News
NewAmsterdam Pharma Company N.V. Announces Positive CHMP Opinion For Obicetrapib And Obicetrapib/Ezetimibe
NAMS•
Schrodinger signs strategic collaboration, software agreement with Bristol Myers Squibb for Bunsen AI co-scientist deployment
SDGR•
Onconetix subsidiary Proteomedix names co-founder Ralph Schiess to board
ONCO•
CPC oil loadings falter over safety issues and tanker shortages
XLE•
ScanSource schedules fiscal 2026 Q4, full-year results release and earnings call
SCSC•